Rachel S Kerr

3PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 10, 2021
Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials.

Jun Yin, Mohamed E Salem, Jesse G Dixon

|Aug 18, 2021
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database.

Zhaohui Jin, Jesse G Dixon, Jack M Fiskum

|Dec 20, 2019
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.

Timothy Iveson, Kathleen A Boyd, Rachel S Kerr

Pageof 1

Frequent Collaborators

2 joint publications

Zhaohui Jin

2 joint publications

Jesse G Dixon

2 joint publications

Greg Yothers

2 joint publications

Julien Taieb